---
figid: PMC5288226__oncotarget-07-53853-g008
figtitle: Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis
  by increasing levels of ERK1 and 2
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5288226
filename: oncotarget-07-53853-g008.jpg
figlink: /pmc/articles/PMC5288226/figure/F8/
number: F8
caption: MiR-550a-3p exerts its tumor-suppressor role by directly targeting and repressing
  ERK1 and ERK2 and thereby suppresses the oncogenic ERK/RSK cascades, reducing cell
  viability, survival, migration, invasion, tumorigenesis, and metastasis in breast
  cancer cells.
papertitle: Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis
  by increasing levels of ERK1 and 2.
reftext: Jar-Yi Ho, et al. Oncotarget. 2016 Aug 16;7(33):53853-53868.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9580012
figid_alias: PMC5288226__F8
figtype: Figure
redirect_from: /figures/PMC5288226__F8
ndex: 03d070ca-deda-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5288226__oncotarget-07-53853-g008.html
  '@type': Dataset
  description: MiR-550a-3p exerts its tumor-suppressor role by directly targeting
    and repressing ERK1 and ERK2 and thereby suppresses the oncogenic ERK/RSK cascades,
    reducing cell viability, survival, migration, invasion, tumorigenesis, and metastasis
    in breast cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tie
  - Ras85D
  - InR
  - drk
  - Sos
  - ras
  - Ras64B
  - Raf
  - Erk7
  - rl
  - S6kII
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K1
  - EPHB2
  - MAPK1
  - MAPK3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - Cancer
  - Noonan syndrome
---
